Task: Answer the multiple-choice question.
Question: Which compound has a 0.634% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a CCC(C)(C)n1nnnc1C(C(C)C)N1CCN(C)CC1.Cl
b COc1cc(Cl)c(C)cc1N1C(=O)CN(Cc2ccccc2)C1=S
c Nc1ccc(Nc2ccc([N+](=O)[O-])cc2[N+](=O)[O-])cc1
Answer: b. COc1cc(Cl)c(C)cc1N1C(=O)CN(Cc2ccccc2)C1=S
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1cc(Cl)c(C)cc1N1C(=O)CN(Cc2ccccc2)C1=S
COc1cc(Cl)c(C)cc1N1C(=O)CN(Cc2ccccc2)C1=S
1-benzyl-3-(4-chloro-2-methoxy-5-methylphenyl)-2-sulfanylideneimidazolidin-4-one